174 related articles for article (PubMed ID: 24887406)
1. Uridine prevents tamoxifen-induced liver lipid droplet accumulation.
Le TT; Urasaki Y; Pizzorno G
BMC Pharmacol Toxicol; 2014 May; 15():27. PubMed ID: 24887406
[TBL] [Abstract][Full Text] [Related]
2. Disruption of uridine homeostasis links liver pyrimidine metabolism to lipid accumulation.
Le TT; Ziemba A; Urasaki Y; Hayes E; Brotman S; Pizzorno G
J Lipid Res; 2013 Apr; 54(4):1044-57. PubMed ID: 23355744
[TBL] [Abstract][Full Text] [Related]
3. Uridine prevents fenofibrate-induced fatty liver.
Le TT; Urasaki Y; Pizzorno G
PLoS One; 2014; 9(1):e87179. PubMed ID: 24475249
[TBL] [Abstract][Full Text] [Related]
4. Uridine affects liver protein glycosylation, insulin signaling, and heme biosynthesis.
Urasaki Y; Pizzorno G; Le TT
PLoS One; 2014; 9(6):e99728. PubMed ID: 24918436
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of bicyclol on tetracycline-induced fatty liver in mice.
Yu HY; Wang BL; Zhao J; Yao XM; Gu Y; Li Y
Toxicology; 2009 Jul; 261(3):112-8. PubMed ID: 19427351
[TBL] [Abstract][Full Text] [Related]
6. Chronic Uridine Administration Induces Fatty Liver and Pre-Diabetic Conditions in Mice.
Urasaki Y; Pizzorno G; Le TT
PLoS One; 2016; 11(1):e0146994. PubMed ID: 26789264
[TBL] [Abstract][Full Text] [Related]
7. Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: A propensity score-matched cohort study.
Hong N; Yoon HG; Seo DH; Park S; Kim SI; Sohn JH; Rhee Y
Eur J Cancer; 2017 Sep; 82():103-114. PubMed ID: 28651157
[TBL] [Abstract][Full Text] [Related]
8. Protective role of thymoquinone against liver damage induced by tamoxifen in female rats.
Suddek GM
Can J Physiol Pharmacol; 2014 Aug; 92(8):640-4. PubMed ID: 24941454
[TBL] [Abstract][Full Text] [Related]
9. [Drug-induced Nonalcoholic Steatohepatitis].
Miyamura M; Yokota J; Saibara T
Yakugaku Zasshi; 2016; 136(4):579-82. PubMed ID: 27040342
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis.
Cole LK; Jacobs RL; Vance DE
Hepatology; 2010 Oct; 52(4):1258-65. PubMed ID: 20658461
[TBL] [Abstract][Full Text] [Related]
11. Incidence and risk factors for non-alcoholic steatohepatitis in females treated with tamoxifen for breast cancer.
Akhondi-Meybodi M; Mortazavy-Zadah MR; Hashemian Z; Moaiedi M
Arab J Gastroenterol; 2011 Mar; 12(1):34-6. PubMed ID: 21429453
[TBL] [Abstract][Full Text] [Related]
12. Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis.
Saibara T; Onishi S; Ogawa Y; Yoshida S; Enzan H
Lancet; 1999 May; 353(9166):1802. PubMed ID: 10348023
[No Abstract] [Full Text] [Related]
13. Protective effects of various ratios of DHA/EPA supplementation on high-fat diet-induced liver damage in mice.
Shang T; Liu L; Zhou J; Zhang M; Hu Q; Fang M; Wu Y; Yao P; Gong Z
Lipids Health Dis; 2017 Mar; 16(1):65. PubMed ID: 28356106
[TBL] [Abstract][Full Text] [Related]
14. Size and oxidative susceptibility of low-density lipoprotein particles in breast cancer patients with tamoxifen-induced fatty liver.
Wakatsuki A; Ogawa Y; Saibara T; Okatani Y; Fukaya T
J Clin Endocrinol Metab; 2002 Aug; 87(8):3676-81. PubMed ID: 12161495
[TBL] [Abstract][Full Text] [Related]
15. Metformin prevents hepatic steatosis by regulating the expression of adipose differentiation-related protein.
Liu F; Wang C; Zhang L; Xu Y; Jang L; Gu Y; Cao X; Zhao X; Ye J; Li Q
Int J Mol Med; 2014 Jan; 33(1):51-8. PubMed ID: 24253218
[TBL] [Abstract][Full Text] [Related]
16. Uridine attenuates obesity, ameliorates hepatic lipid accumulation and modifies the gut microbiota composition in mice fed with a high-fat diet.
Liu Y; Xie C; Zhai Z; Deng ZY; De Jonge HR; Wu X; Ruan Z
Food Funct; 2021 Mar; 12(4):1829-1840. PubMed ID: 33527946
[TBL] [Abstract][Full Text] [Related]
17. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
[TBL] [Abstract][Full Text] [Related]
18. Toremifene-induced fatty liver and NASH in breast cancer patients with breast-conservation treatment.
Hamada N; Ogawa Y; Saibara T; Murata Y; Kariya S; Nishioka A; Terashima M; Inomata T; Yoshida S
Int J Oncol; 2000 Dec; 17(6):1119-23. PubMed ID: 11078796
[TBL] [Abstract][Full Text] [Related]
19. [Cirrhosis with non alcoholic steatohepatitis: role of tamoxifen].
Dray X; Tainturier MH; De La Lande P; Marty O; Mallet L
Gastroenterol Clin Biol; 2000 Nov; 24(11):1122-3. PubMed ID: 11139682
[TBL] [Abstract][Full Text] [Related]
20. Uridine supplementation antagonizes zalcitabine-induced microvesicular steatohepatitis in mice.
Lebrecht D; Vargas-Infante YA; Setzer B; Kirschner J; Walker UA
Hepatology; 2007 Jan; 45(1):72-9. PubMed ID: 17187420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
